F Antibody : FITC

Katalog-Nummer OABF00317-FITC

Size : 100ul

Marke : Aviva Systems Biology

Weitere Informationen anfordern

Contact local distributor :


Telefonnummer : +1 850 650 7790

F Antibody : FITC (OABF00317-FITC)

Click here to learn more about Aviva's By-Request Conjugation Service.
Datasheets/ManualsPrintable datasheet for OABF00317-FITC
Product Info
Predicted Species ReactivityMeasles virus
Product FormatLiquid. Purified antibody supplied in 1x PBS buffer.
ClonalityPolyclonal
IsotypeIgG
HostRabbit
ConjugationFITC: Fluorescein Isothiocyanate
ApplicationWB, IHC-P, IF
Additional InformationSubcellular location: Cytoplasm
Reconstitution and StorageAll conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil). Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.
ImmunogenKLH conjugated synthetic peptide derived from Measles virus fusion protein
PurificationPurified by Protein A.
Concentration1 mg/ml
Application InfoWB(1:100-1000)
IHC-P(1:100-500)
IF(1:50-200)
Gene SymbolF
Alias SymbolsFusion glycoprotein F, F
NCBI Gene Id1489800
Description of TargetClass I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and plasma cell membrane fusion, the heptad repeat (HR) regions assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and plasma cell membranes. Directs fusion of viral and cellular membranes leading to delivery of the nucleocapsid into the cytoplasm. This fusion is pH independent and occurs directly at the outer cell membrane. The trimer of F1-F2 (F protein) probably interacts with H at the virion surface. Upon HN binding to its cellular receptor, the hydrophobic fusion peptide is unmasked and interacts with the cellular membrane, inducing the fusion between cell and virion membranes. Later in infection, F proteins expressed at the plasma membrane of infected cells could mediate fusion with adjacent cells to form syncytia, a cytopathic effect that could lead to tissue necrosis (By similarity).
Uniprot IDP69353